Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CDLX
CDLX logo

CDLX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.709
Open
0.660
VWAP
0.67
Vol
754.94K
Mkt Cap
38.31M
Low
0.640
Amount
506.97K
EV/EBITDA(TTM)
--
Total Shares
57.61M
EV
183.29M
EV/OCF(TTM)
17.70
P/S(TTM)
0.17
Cardlytics, Inc. provides a commerce media platform. Through the Cardlytics platform, its financial media network, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States (U.S.) and United Kingdom (U.K.). The Cardlytics platform helps marketers find potential new customers that are active in their category but not shopping with them, or to grow their business with existing customers. The Cardlytics platform also provides its marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of its partners' customers. The Cardlytics platform helps solve fundamental problems for its financial institutions (FI partners).
Show More

Events Timeline

(ET)
2026-05-07
16:20:00
Cardlytics Sees Q2 Revenue of $35M-$40M
select
2026-05-07
16:20:00
Cardlytics Q1 Revenue at $34.32M, Below Consensus
select
2026-03-04 (ET)
2026-03-04
16:20:00
Sees Q1 Adjusted EBITDA of -$7.5M to -$3.5M
select
2026-03-04
16:20:00
Cardlytics Reports Q4 Revenue of $56.1M, Exceeding Expectations
select
2026-01-26 (ET)
2026-01-26
08:20:00
Par Technology to Acquire Bridg from Cardlytics for $27.5M
select
2025-12-18 (ET)
2025-12-18
08:30:00
Cardlytics Appoints David Evans as New CFO
select
2025-11-07 (ET)
2025-11-07
08:45:02
Significant Borrowing Rate Hikes Among Liquid Assets
select

News

seekingalpha
9.5
05-08seekingalpha
Cardlytics Q1 2026 Earnings Call Insights
  • Performance Decline: Cardlytics reported Q1 revenue of $34.3 million, a 39% year-over-year decrease, indicating challenges in retaining clients amidst macroeconomic pressures, particularly in the travel and hospitality sectors where budget approvals are delayed.
  • Improved Financial Flexibility: The successful closure of the Bridg transaction has significantly enhanced the company's financial flexibility, with Q2 revenue expected to range between $35 million and $40 million, reflecting confidence in future growth.
  • Increased Customer Engagement: The Double Days program successfully attracted 250,000 new activators, demonstrating effective strategies in consumer engagement, although overall performance still faces challenges.
  • Progress Towards Self-Sustainability: The company achieved a positive adjusted EBITDA of $0.2 million in Q1, a significant improvement from a negative $4.1 million in the same quarter last year, showcasing notable advancements in cost control and operational efficiency.
seekingalpha
9.5
05-07seekingalpha
Cardlytics Q1 Earnings Beat Expectations, Shares Rise
  • Earnings Highlights: Cardlytics reported a Q1 GAAP EPS of -$0.11, beating expectations by $0.26, indicating an improvement in profitability despite a significant 44.6% year-over-year revenue decline.
  • Revenue Performance: The Q1 revenue of $34.32M fell short of expectations by $2.78M, reflecting challenges in the market environment that could impact future growth potential.
  • Future Guidance: The company anticipates Q2 billings to range from $61.0M to $67.0M, representing a year-over-year growth of 32% to 38%, demonstrating confidence in market recovery, although revenue expectations remain under pressure.
  • Adjusted Financial Metrics: Expected adjusted EBITDA is projected between -$2.7M and $1.3M, indicating efforts in cost control and operational optimization, though attention is still needed on the recovery of profitability.
seekingalpha
9.5
05-06seekingalpha
Cardlytics Scheduled to Announce Q1 Earnings on May 7th
  • Earnings Announcement Date: Cardlytics is set to release its Q1 earnings on May 7th after market close, with a consensus EPS estimate of -$0.24, reflecting a 14.3% year-over-year decline, which could negatively impact investor sentiment.
  • Revenue Decline Forecast: The anticipated revenue of $37.1 million represents a significant 40.1% year-over-year drop, indicating challenges the company faces in the current economic climate, which may affect future investment and operational strategies.
  • Historical Performance Review: Over the past two years, Cardlytics has beaten EPS estimates 100% of the time, while only achieving a 50% beat rate on revenue estimates, highlighting stability in profitability but volatility in revenue growth.
  • Revision Trends: In the last three months, there have been no upward revisions to EPS estimates, with two downward adjustments, and revenue estimates have seen three downward revisions, suggesting a weakening market confidence in the company's future performance, which may impact stock price.
Newsfilter
9.5
04-27Newsfilter
Cardlytics Announces Q1 2026 Financial Results Release Date
  • Earnings Release Schedule: Cardlytics has announced that its financial results for the first quarter ending March 31, 2026, will be released on May 7, 2026, after market close, reflecting the company's commitment to transparency and investor communication.
  • Conference Call Timing: Following the earnings release, Cardlytics will hold a conference call on May 7 at 5:00 PM Eastern Time / 2:00 PM Pacific Time, aimed at providing investors with deeper financial insights and future outlook.
  • Webcast Access: Investors can access the live audio webcast on the Cardlytics Investor Relations website, enhancing interaction between the company and its investors and improving the efficiency of information dissemination.
  • Company Overview: Cardlytics operates a commerce media platform powered by first-party purchase data, covering approximately half of card-based transactions in the U.S., helping advertisers and publishers strengthen customer loyalty, which underscores its significant market position.
Newsfilter
8.5
03-24Newsfilter
Cardlytics Completes Sale of Bridg Business to PAR Technology
  • Transaction Closure: Cardlytics has announced the completion of the sale of its Bridg business to PAR Technology, receiving 1,810,222 shares of PAR common stock, marking a significant milestone in the company's strategic focus.
  • Financial Asset Enhancement: The CFO of Cardlytics stated that the PAR equity received will serve as a meaningful financial asset, with plans to monetize it strategically based on market conditions, thereby significantly strengthening the company's balance sheet.
  • Operational Model Simplification: By selling the Bridg assets, Cardlytics is further simplifying its operating model and concentrating resources on scaling its core platform, which is expected to enhance the company's competitive advantage and long-term value creation potential.
  • Employee Transition: Employees and operations associated with the Bridg business have transitioned to PAR Technology as part of the asset transfer, ensuring business continuity and integration, which further supports Cardlytics' strategic shift.
seekingalpha
9.5
03-04seekingalpha
Cardlytics Q4 Earnings Exceed Expectations
  • Earnings Beat: Cardlytics reported a Q4 non-GAAP EPS of $0.03, surpassing expectations by $0.10, indicating an improvement in profitability despite a decline in overall revenue.
  • Revenue and Billings Decline: Q4 revenue was $56.1M, down 24.2% year-over-year but still exceeding expectations by $1.64M, showcasing the company's resilience amid market challenges, although total annual revenue fell 16.2% to $233.3M.
  • Cash Flow Improvement: Net cash provided by operating activities in Q4 was $13.0M, an increase of $10.0M compared to the same period last year, demonstrating significant improvement in cash management that supports future investments and operations.
  • User Growth vs. Revenue Decline: Despite achieving 227.0 million MQUs in Q4, an 18.4% increase year-over-year, the average revenue per user (ACPU) fell 35.0% to $0.12, reflecting challenges in balancing user growth with revenue quality.
Wall Street analysts forecast CDLX stock price to rise
4 Analyst Rating
Wall Street analysts forecast CDLX stock price to rise
0 Buy
3 Hold
1 Sell
Hold
Current: 0.000
sliders
Low
1.50
Averages
1.63
High
2.00
Current: 0.000
sliders
Low
1.50
Averages
1.63
High
2.00
Lake Street
Hold
downgrade
$1
AI Analysis
2026-05-08
Reason
Lake Street
Price Target
$1
AI Analysis
2026-05-08
downgrade
Hold
Reason
Lake Street lowered the firm's price target on Cardlytics to $1 from $1.25 and keeps a Hold rating on the shares. Q1 results appeared to show stabilization and early signs of execution, says the analyst, who adds "we are not there yet, but Q1 signs are encouraging."
Evercore ISI
In Line
downgrade
$2 -> $1
2026-03-06
Reason
Evercore ISI
Price Target
$2 -> $1
2026-03-06
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on Cardlytics to $1 from $2 and keeps an In Line rating on the shares following the company's Q4 report and Q1 guidance.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CDLX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cardlytics Inc (CDLX.O) is 36.50, compared to its 5-year average forward P/E of -3.53. For a more detailed relative valuation and DCF analysis to assess Cardlytics Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.53
Current PE
36.50
Overvalued PE
55.03
Undervalued PE
-62.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-122.34
Current EV/EBITDA
-14.83
Overvalued EV/EBITDA
125.11
Undervalued EV/EBITDA
-369.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.49
Current PS
0.23
Overvalued PS
5.98
Undervalued PS
-1.01

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

i want peeny stock options
Intellectia · 131 candidates
Market Cap: <= 2.00BPrice: $0.50 - $5.00Beta: HighRiskList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
EVTV logo
EVTV
Envirotech Vehicles Inc
23.92M
MAXN logo
MAXN
Maxeon Solar Technologies Ltd
26.08M
LTRN logo
LTRN
Lantern Pharma Inc
26.22M
CDLX logo
CDLX
Cardlytics Inc
53.20M
ANVS logo
ANVS
Annovis Bio Inc
59.74M
FBIO logo
FBIO
Fortress Biotech Inc
77.93M
long call to buy today with highest profit
Intellectia · 13 candidates
Moving Average Relationship: PriceAboveMA20Is Optionable: TrueOption Sentiments: BullishOne Week Rise Prob: >= 60One Week Predict Return: >= 8.0%
Ticker
Name
Market Cap$
top bottom
SANM logo
SANM
Sanmina Corp
7.08B
AGIO logo
AGIO
Agios Pharmaceuticals Inc
1.98B
RGP logo
RGP
Resources Connection Inc
124.96M
INGM logo
INGM
Ingram Micro Holding Corp
5.40B
EQX logo
EQX
Equinox Gold Corp
11.41B
HYFT logo
HYFT
MindWalk Holdings Corp
52.78M
tech stocks bullish today
Intellectia · 21 candidates
Sector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology Equipment, Telecommunications ServicesIndustry: Communications & Networking, Integrated Hardware & Software, Semiconductors & Semiconductor Equipment, Software & IT ServicesPrice Change Pct: >= $0.01Relative Vol: >= 1.20List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Option Sentiments: Bullish
Ticker
Name
Market Cap$
top bottom
BRZE logo
BRZE
Braze Inc
2.44B
BZUN logo
BZUN
Baozun Inc
144.10M
CDLX logo
CDLX
Cardlytics Inc
58.36M
INVE logo
INVE
Identiv Inc
93.35M
FROG logo
FROG
Jfrog Ltd
5.64B
KOPN logo
KOPN
Kopin Corp
405.56M
stocks to buy under 2 $ today
Intellectia · 46 candidates
Market Cap: >= 50.00MPrice: $0.20 - $2.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
PROP logo
PROP
Prairie Operating Co
84.70M
REI logo
REI
Ring Energy Inc
301.53M
MVIS logo
MVIS
MicroVision Inc
215.19M
BLND logo
BLND
Blend Labs Inc
442.24M
HAIN logo
HAIN
Hain Celestial Group Inc
56.02M
UPXI logo
UPXI
Upexi Inc
81.62M
yea US penny stocks
Intellectia · 16 candidates
Price: $0.10 - $5.00Volume: >= 300,000Rsi Category: moderate, overboughtPrice Change Pct: $0.00 - $15.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
APYX logo
APYX
Apyx Medical Inc
166.48M
CAPT logo
CAPT
Captivision Inc
19.92M
APM logo
APM
Aptorum Group Ltd
9.85M
RNXT logo
RNXT
RenovoRx Inc
40.68M
TRON logo
TRON
TRON Inc
622.85M
CDLX logo
CDLX
Cardlytics Inc
50.19M

Whales Holding CDLX

C
CAS Investment Partners, LLC
Holding
CDLX
+0.78%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cardlytics Inc (CDLX) stock price today?

The current price of CDLX is 0.665 USD — it has decreased -1.48

What is Cardlytics Inc (CDLX)'s business?

Cardlytics, Inc. provides a commerce media platform. Through the Cardlytics platform, its financial media network, marketers can deliver advertising content to customers that allows them to earn rewards, which are funded with a portion of the fees it collects from marketers. It maintains the Cardlytics platform in both the United States (U.S.) and United Kingdom (U.K.). The Cardlytics platform helps marketers find potential new customers that are active in their category but not shopping with them, or to grow their business with existing customers. The Cardlytics platform also provides its marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of its partners' customers. The Cardlytics platform helps solve fundamental problems for its financial institutions (FI partners).

What is the price predicton of CDLX Stock?

Wall Street analysts forecast CDLX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDLX is1.63 USD with a low forecast of 1.50 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cardlytics Inc (CDLX)'s revenue for the last quarter?

Cardlytics Inc revenue for the last quarter amounts to 34.32M USD, decreased -44.56

What is Cardlytics Inc (CDLX)'s earnings per share (EPS) for the last quarter?

Cardlytics Inc. EPS for the last quarter amounts to -0.08 USD, decreased -69.23

How many employees does Cardlytics Inc (CDLX). have?

Cardlytics Inc (CDLX) has 275 emplpoyees as of May 14 2026.

What is Cardlytics Inc (CDLX) market cap?

Today CDLX has the market capitalization of 38.31M USD.